Benedet, Andréa L. http://orcid.org/0000-0001-8219-1741
Brum, Wagner S.
Hansson, Oskar
Karikari, Thomas K.
Zimmer, Eduardo R.
Zetterberg, Henrik
Blennow, Kaj
Ashton, Nicholas J.
,
Funding for this research was provided by:
hjärnfonden (FO2017-0243)
University of Gothenburg
Article History
Received: 4 August 2021
Accepted: 17 November 2021
First Online: 7 February 2022
Declarations
:
: All enrolled participants or authorized representatives provided informed consent, approved by ADNI center’s respective Institutional Review Boards, which were in accordance with the ethical standards of the institutional and/or national research committee and with the principles of the 1964 Declaration of Helsinki.
: Not applicable.
: HZ has served at scientific advisory boards for Eisai, Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics, Nervgen, AZTherapies, and CogRx, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. OH has acquired research support (for the institution) from AVID Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, Fujirebio, GE Healthcare, Pfizer, and Roche. In the past 2 years, he has received consultancy/speaker fees from Amylyx, Alzpath, Biogen, Cerveau, Fujirebio, Genentech, Roche, and Siemens.